This paper will add value to the previous researches by providing additional information and practical knowledge by examining the childhood leukaemia. The objective is to determine the major risk factors of leukaemia cases, based on the historical analysis of the cases and drawing parallels between location, age, genetics and other factors that potentially can contribute or even cause the disease Mar 29, · Chronic Myelogenous Leukemia Research Papers There are many different types of cancers that exist, but the one that will be the focus of this paper will be Leukemia. Leukemia is a type of blood-forming cancer, which occurs when there is an increased of uncontrolled immature or mature cells in the bone marrow For the 51 patients, median age was 70 years (range ), 94% had diffuse large B-cell lymphoma (DLBCL) and 55% were high-intermediate or high-risk according to the age-adjusted international prognostic index. A mean of 6 cycles was delivered, with dose
Leukemia Research Paper - Research Paper Examples - EssayEmpire
Download Guide for Authors in PDF. Leukemia Research is an international journal which brings comprehensive and current information to all health care professionals involved in basic and applied clinical research in hematological malignancies.
The editors encourage the submission of articles relevant to hematological malignancies. The Journal scope includes reporting studies of cellular and molecular biologygeneticsimmunologyepidemiologyclinical evaluationand therapy of these diseases.
Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services. Please see our Guide for Authors for information on article submission. If leukemia research paper require any further information or help, please visit our Support Center You are also welcome to submit to Leukemia Research's open access companion title, Leukemia Research Reports.
Your Paper Your Way We now differentiate between the requirements for new and revised submissions. You may choose to submit your manuscript as a single Word or PDF file to be used in the refereeing process. Only when your paper is at the revision stage, leukemia research paper you be requested to put your paper in to a 'correct format' for acceptance and provide the items required for the publication of your article.
To find out more, leukemia research paper, please visit the Preparation section below. Leukemia Research an international journal which brings comprehensive and current information to all health care professionals involved in basic and applied clinical research in hematological malignancies.
The Journal scope includes reporting studies of cellular and molecular biology, genetics, immunology, epidemiology, leukemia research paper, clinical evaluation, and therapy of these diseases. Word count limit does not include the abstract references, acknowledgement document, figures and tables. Commentaries are contributions invited by the Editor which should be concerned with matters of opinion and criticism on contributions published in the journal and other matters of interest to researchers in our field, often invited by the Editor to present new perspectives and advance understanding of controversial issues by provoking debate and comment.
Submission checklist You can use this list to carry out a final check of your submission before you send it to leukemia research paper journal for review. Please check the relevant section in this Guide for Authors for more details, leukemia research paper. Ensure that the following items are present:.
For further information, visit our Support Center. The Journal allows up to 6 months for authors to make the suggested revisions to their manuscript. Note: If you do not submit your revisions by the 6 month date your paper will be withdrawn. Ethics in publishing Please see our information on Ethics in publishing.
Studies in humans and animals If the work involves the use of human subjects, the author should ensure that the leukemia research paper described has been carried out in accordance with The Code of Ethics of the World Medical Association Leukemia research paper of Helsinki for experiments involving humans, leukemia research paper. The manuscript should be in line with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and aim for the inclusion of representative human populations sex, age and ethnicity as per those recommendations.
The terms sex and gender should be used correctly. Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed. Informed consent and patient details Studies on patients or volunteers require ethics committee approval and informed consent, which should be documented in the paper.
Appropriate consents, permissions and releases must be obtained where an author wishes to leukemia research paper case details or other personal information or images of patients and any other individuals in an Elsevier publication.
Written consents must be retained by the author but copies should not be provided to the journal. Only if specifically requested by the journal in exceptional circumstances for example if a legal issue arises the author must provide copies of the consents or evidence that such consents have been obtained.
For more information, please review the Elsevier Policy on the Use of Images or Personal Information of Patients or other Individuals. Unless you have written permission from the patient or, where applicable, the next of kinthe personal details of any patient included in any part of the article and in any supplementary materials including all illustrations and videos must be removed before submission.
Declaration of interest All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence bias their work. Authors leukemia research paper disclose any interests in two places: 1. A summary declaration of interest statement in the title page file if double anonymized or the manuscript file if single anonymized.
If there are no interests to declare then please state this: 'Declarations of interest: none'. Detailed disclosures as part of a separate Declaration of Interest form, which forms part of the journal's official records. It is important for potential interests to be declared in both places and that the information matches. More information.
Submission declaration and verification Submission of an article implies that the work described has not been published previously except in the form of an abstract, a published lecture or academic thesis, see ' Multiple, redundant or concurrent publication ' for more informationthat it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, leukemia research paper, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent leukemia research paper the copyright-holder.
To verify originality, your article may be checked by the originality detection service Crossref Similarity Check.
Preprints Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.
on a preprint server will not count as prior publication see ' Multiple, leukemia research paper, redundant or concurrent publication ' for more information.
Use of inclusive language Inclusive language acknowledges diversity, leukemia research paper, conveys respect to all people, leukemia research paper sensitive to differences, and promotes equal opportunities. Content should make no assumptions about leukemia research paper beliefs or commitments of any reader; contain nothing which might imply that one leukemia research paper is superior to another on the grounds of age, gender, race, leukemia research paper, leukemia research paper, culture, sexual orientation, disability or health condition; and use inclusive language throughout.
When coding terminology is used, we recommend to avoid offensive or exclusionary leukemia research paper such as "master", "slave", "blacklist" and "whitelist". We suggest using alternatives that are more appropriate and self- explanatory such as "primary", "secondary", "blocklist" and "allowlist". These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive.
Authorship All authors should have made substantial contributions to all of the following: 1 the conception and design of the study, or acquisition of data, leukemia research paper, or analysis and interpretation of data, 2 drafting the article or revising it critically for important intellectual content, leukemia research paper, 3 final approval of the version to be submitted. Role of Corresponding Author Please note: there is only one corresponding author of the manuscript.
The corresponding author is the one that submits the manuscript and has the duty to ensure that all of the named authors have seen and approved the original manuscript and subsequent revisions. Each author leukemia research paper have participated sufficiently in the work to take public responsibility for the content.
The corresponding author should also ensure that those who have contributed to the research are acknowledged appropriately either as a co-author or in the Acknowledgements. In addition, the corresponding author has the prime responsibility for ensuring the paper is correctly prepared according to the Guide for Authors, leukemia research paper. Submitted manuscripts not complying with the Guide for Authors may be returned to the authors.
Changes to authorship Authors are expected to leukemia research paper carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names leukemia research paper the authorship list leukemia research paper be made only before the manuscript has been accepted and only if approved by the journal Editor.
To request such a change, the Editor must receive the following from the corresponding author : leukemia research paper the reason for the change in author list and b written confirmation e-mail, letter from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.
Only in exceptional circumstances leukemia research paper the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum.
Clinical trial results In line with the position of the International Committee of Medical Journal Editors, leukemia research paper, the journal will not consider results posted in the same clinical trials registry in which primary registration resides to be prior publication if the results posted are presented in the form of a brief structured less than words abstract or table.
However, leukemia research paper, divulging results in other circumstances e. Authors should fully disclose all posting in registries of results of the same or closely related work. Reporting clinical trials Randomized controlled trials should be presented according to the CONSORT guidelines. At manuscript submission, authors must provide the CONSORT checklist accompanied by a flow diagram that illustrates the progress of leukemia research paper through the trial, including recruitment, enrollment, randomization, withdrawal and completion, leukemia research paper, and a detailed description of the randomization procedure.
The CONSORT checklist and template flow diagram are available online. Registration of clinical trials Registration in a public trials registry is a condition for publication of clinical trials in this journal in accordance with International Committee of Medical Journal Editors recommendations.
Trials must register at or before the onset of patient enrolment. The clinical trial registration number should be included at the end of the abstract of the article.
A clinical trial is defined as any research study leukemia research paper prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects of health outcomes.
Health-related interventions include any intervention used to modify a biomedical or health-related outcome for example drugs, leukemia research paper, surgical procedures, devices, behavioural treatments, dietary interventions, and process-of-care changes.
Health outcomes include any biomedical or health-related measures obtained in patients or participants, including pharmacokinetic measures and adverse events. Purely observational studies those in which the assignment of the medical intervention is not at the discretion of the investigator will not require leukemia research paper. Article transfer service This journal is part of our Article Transfer Service. This means that if the Editor feels your article is more suitable in one of our other participating journals, then you may be asked to consider transferring the article to one of those.
If you agree, your article will be transferred automatically on your behalf with no need to reformat. Please note that your article will be reviewed again by the new journal, leukemia research paper. Copyright Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' see more information on this.
An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement. Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions.
Permission of the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations. If excerpts from other copyrighted works are included, leukemia research paper, the author s must obtain written permission from the copyright owners and credit the source s in the article.
Elsevier has preprinted forms for use by authors in these cases. Author rights As an author you or your employer or institution have certain rights to reuse your work. Elsevier supports responsible sharing Find out how you can share your research published in Elsevier journals. If the funding source s had no such involvement then this should be stated. Open access Please visit our Open Access page for more information. Elsevier Researcher Academy Researcher Academy is a free e-learning platform designed to support early and mid-career researchers throughout their research journey.
The "Learn" environment at Researcher Academy offers several interactive modules, webinars, downloadable guides and resources to guide you through the process of writing for research and going through peer review.
Feel free to use these free resources to improve your submission and navigate the publication process with ease, leukemia research paper. Language usage and editing services Please write your text in good English American or British usage is accepted, but not a mixture of these, leukemia research paper.
Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service available from Elsevier's Author Services. Submission Our online submission system guides you stepwise through the process of entering your article details and uploading your files. The system converts your article files to a single PDF file used in the peer-review process.
The Leukemia \u0026 Lymphoma Society Roundtable - Innovation in Research: Blood Cancers and Beyond
, time: 1:31:22Leukemia Research Articles - National Cancer Institute
This paper will add value to the previous researches by providing additional information and practical knowledge by examining the childhood leukaemia. The objective is to determine the major risk factors of leukaemia cases, based on the historical analysis of the cases and drawing parallels between location, age, genetics and other factors that potentially can contribute or even cause the disease Mar 29, · Chronic Myelogenous Leukemia Research Papers There are many different types of cancers that exist, but the one that will be the focus of this paper will be Leukemia. Leukemia is a type of blood-forming cancer, which occurs when there is an increased of uncontrolled immature or mature cells in the bone marrow Jul 29, · Leukemia Research Results and Study Updates See Advances in Leukemia Research for an overview of recent findings and progress, plus ongoing projects supported by NCI. Drug combination helps children with acute promyelocytic leukemia avoid conventional chemotherapy
No comments:
Post a Comment